Funding Announcements Percussion Rhythmyx braininfo@ninds.nih.gov Copyright 2008, National Institute of Neurological Disorders and Stroke Saturday Sunday http://blogs.law.harvard.edu/tech/rss http://www.ninds.nih.gov/funding/funding_announcements/allcurrent.htm The National Institute of Neurological Disorders and Stroke (NINDS) intends to issue a Request for Applications (RFA) to provide support for a redesigned and enhanced Parkinson’s Disease Data Organizing Center (PD-DOC). NINDS is committed to facilitating the collection and sharing of data related to clinical and translational research in Parkinson’s disease, and the active development of a centralized repository of clinical data from both observational studies and clinical trials will strengthen the data sharing efforts in the Parkinson’s disease research community and establish important links between research efforts. http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-10-003.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-10-003.htm This program provides three to five years of mentored career development support to clinically trained faculty members in strong research environments to enable them to gain skills and experience in aging research under the guidance of a mentor or mentors, and to establish an independent program of research in this field. Clinically trained professionals or individuals with a clinical degree who are interested in further career development in biomedical research that is patient-oriented should refer to the Paul B. Beeson Mentored Patient-Oriented Research Development (K23) Award in Aging [AG-10-011].The program also includes an annual meeting that allows opportunities to partner with national mentors and fellow awardees. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-AG-10-010.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-AG-10-010.htm This program provides three to five years of mentored career development support to clinically trained faculty members in strong research environments who have made a commitment to focus their research endeavors on patient-oriented research. The award will enable them to gain skills and experience in aging research under the guidance of a mentor or mentors, and to establish an independent program of research in this field. Clinically trained professionals or individuals with a clinical degree who are interested in further career development in biomedical research that is not patient-oriented should refer to the Paul B. Beeson Clinical Scientist Career Development Award in Aging (K08) [AG-10-010].The program also includes an annual meeting that allows opportunities to partner with national mentors and fellow awardees. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-AG-10-011.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-AG-10-011.htm This Funding Opportunity Announcement (FOA) requests applications for exploratory/developmental translational research on therapeutics for reducing mortality and morbidity caused by acute exposures to chemical threat agents. Chemical threats include traditional chemical warfare nerve agents such as sarin and VX, toxic industrial chemicals such as cyanide and chlorine, and toxic agricultural chemicals such as parathion and sodium fluoroacetate. Projects supported by this FOA are expected to generate preliminary data that would enable the development of competitive applications for more extensive support from the NIH CounterACT program (see www.ninds.nih.gov/counteract for a description) and other related research and development programs. http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-019.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-019.htm Participating Institutes and Centers of the NIH invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. The BRGs support multi-disciplinary research performed in a single laboratory or by a small number of investigators that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research. http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-009.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-009.htm This Funding Opportunity Announcement (FOA) is intended to encourage innovation and high risk/impact bioengineering research in new areas. While minimal or no preliminary data are expected to be described in the application, applications should clearly indicate the significance of the proposed work and that the proposed research and/or development is scientifically sound, that the qualifications of the investigators are appropriate, and that resources available to the investigators are adequate. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research. The research proposed under this program can explore approaches and concepts new to a particular substantive area; research and development of new technologies, techniques or methods; or initial research and development of data upon which significant future research may be built. http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-010.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-010.htm The purpose of this notice is to change the multiple receipt dates per year for PAR-08-116, “NINDS Institutional Center Core Grants to Support Neuroscience Research (P30),” to one receipt date per year. http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-10-001.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-10-001.htm The National Institute of Neurological Disorders and Stroke (NINDS) invites new and competing renewal applications for the Morris K. Udall Centers of Excellence for Parkinson’s Disease Research program. Proposed Centers must involve multidisciplinary teams engaged in integrative basic, translational and clinical research on Parkinson’s disease (PD), with the primary objective of transforming this research into the development of new treatments. Investigations on related parkinsonian disorders may be included, to the extent that these inform and/or expand research on PD. Accomplishment of the stated goals of the Center, and of each project, must require substantial collaborative efforts and the utilization of common resource cores. All proposed Centers must include a pre-clinical and/or clinical translational research project. In this context, pre-clinical translation is defined as pre-IND/IDE (Investigational New Drug/Investigational Device Exemption) stage research on potential therapeutic or diagnostic candidates. Clinical translational projects are early-stage projects in human subjects that are designed as first steps toward transformation of scientific discoveries arising from basic research, clinical research or population studies into new modalities for the prevention, treatment and cure of PD. All Centers are required to have an Administrative Core; inclusion of other research and core components is flexible within stated budget limits. Inclusion of a clinical component, a clinical translational research project plus a clinical resource core, is encouraged, as is emphasis on training and public outreach activities. The Udall Center Director (PI) must be an established leader in scientific research with visionary leadership skills and proven expertise in research project and personnel management. Eligible institutions must demonstrate commitment to and support for the establishment and continuation of the proposed Udall Center. Successful applicants will participate in a network of existing Udall Centers to foster the translation of new scientific findings and technological developments into novel treatments for PD. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-10-001.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-10-001.htm The purpose of this Funding Opportunity Announcement (FOA), “Mechanisms, Models, Measurement, & Management in Pain Research” issued by the National Institute of Nursing Research (NINR), in conjunction with members of the NIH Pain Consortium as listed above, is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-006-007-008.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-10-006-007-008.htm This funding opportunity announcement (FOA) encourages research grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-001.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-001.htm The National Cancer Institute (NCI), the National Institute of Dental and Craniofacial Research (NIDCR), and the National Institute of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health (NIH), invite new or renewal (competing) applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund 5-year P50 SPORE grants to support state-of-the-art investigator-initiated research that will contribute to improved detection, diagnosis, treatment, and prevention of an organ-specific cancer (or a related group of cancers). SPOREs are expected not only to conduct a wide spectrum of research activities, but also to contribute significantly to the development of specialized research COREs, improved research model systems, and collaborative research projects with other institutions. The research supported through this program must be translational in nature and must always be based upon knowledge of human biology stemming from research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-003.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-10-003.htm